Literature DB >> 22912404

Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism.

Whitney H Brown1, Matthew P Gillum, Hui-Young Lee, Joao Paulo G Camporez, Xian-man Zhang, Jin Kwon Jeong, Tiago C Alves, Derek M Erion, Blas A Guigni, Mario Kahn, Varman T Samuel, Benjamin F Cravatt, Sabrina Diano, Gerald I Shulman.   

Abstract

Fatty acid amide hydrolase (FAAH) knockout mice are prone to excess energy storage and adiposity, whereas mutations in FAAH are associated with obesity in humans. However, the molecular mechanism by which FAAH affects energy expenditure (EE) remains unknown. Here we show that reduced energy expenditure in FAAH(-/-) mice could be attributed to decreased circulating triiodothyronine and thyroxine concentrations secondary to reduced mRNA expression of both pituitary thyroid-stimulating hormone and hypothalamic thyrotropin-releasing hormone. These reductions in the hypothalamic-pituitary-thyroid axis were associated with activation of hypothalamic peroxisome proliferating-activated receptor γ (PPARγ), and increased hypothalamic deiodinase 2 expression. Infusion of NAEs (anandamide and palmitoylethanolamide) recapitulated increases in PPARγ-mediated decreases in EE. FAAH(-/-) mice were also prone to diet-induced hepatic insulin resistance, which could be attributed to increased hepatic diacylglycerol content and protein kinase Cε activation. Our data indicate that FAAH deletion, and the resulting increases in NAEs, predispose mice to ectopic lipid storage and hepatic insulin resistance by promoting centrally mediated hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22912404      PMCID: PMC3443187          DOI: 10.1073/pnas.1212887109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Naoki Kumashiro; Derek M Erion; Dongyan Zhang; Mario Kahn; Sara A Beddow; Xin Chu; Christopher D Still; Glenn S Gerhard; Xianlin Han; James Dziura; Kitt Falk Petersen; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 2.  Mechanisms for insulin resistance: common threads and missing links.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

3.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Authors:  B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

4.  Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.

Authors:  Anthony P Heaney; Manory Fernando; William H Yong; Shlomo Melmed
Journal:  Nat Med       Date:  2002-10-15       Impact factor: 53.440

5.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.

Authors:  Jin Fu; Silvana Gaetani; Fariba Oveisi; Jesse Lo Verme; Antonia Serrano; Fernando Rodríguez De Fonseca; Anja Rosengarth; Hartmut Luecke; Barbara Di Giacomo; Giorgio Tarzia; Daniele Piomelli
Journal:  Nature       Date:  2003-09-04       Impact factor: 49.962

6.  Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Dongyan Zhang; Jennifer Christianson; Zhen-Xiang Liu; Liqun Tian; Cheol Soo Choi; Susanne Neschen; Jianying Dong; Philip A Wood; Gerald I Shulman
Journal:  Cell Metab       Date:  2010-05-05       Impact factor: 27.287

7.  Peripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregulated lysine acetylation.

Authors:  Bhavapriya Vaitheesvaran; Li Yang; Kirsten Hartil; Sherrye Glaser; Stephen Yazulla; James E Bruce; Irwin J Kurland
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

8.  A role for central nervous system PPAR-γ in the regulation of energy balance.

Authors:  Karen K Ryan; Bailing Li; Bernadette E Grayson; Emily K Matter; Stephen C Woods; Randy J Seeley
Journal:  Nat Med       Date:  2011-05-01       Impact factor: 53.440

9.  Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice.

Authors:  Michael J Jurczak; Ann-Hwee Lee; Francois R Jornayvaz; Hui-Young Lee; Andreas L Birkenfeld; Blas A Guigni; Mario Kahn; Varman T Samuel; Laurie H Glimcher; Gerald I Shulman
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

Review 10.  Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.

Authors:  François R Jornayvaz; Gerald I Shulman
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

View more
  16 in total

1.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 2.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

3.  N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis.

Authors:  Trisha J Grevengoed; Samuel A J Trammell; Michele K McKinney; Natalia Petersen; Rebecca L Cardone; Jens S Svenningsen; Daisuke Ogasawara; Christina C Nexøe-Larsen; Filip K Knop; Thue W Schwartz; Richard G Kibbey; Benjamin F Cravatt; Matthew P Gillum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-18       Impact factor: 11.205

4.  An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides.

Authors:  Trisha J Grevengoed; Samuel Aj Trammell; Jens S Svenningsen; Mikhail V Makarov; Thomas Svava Nielsen; Jens Christian Brings Jacobsen; Jonas T Treebak; Philip C Calder; Marie E Migaud; Benjamin F Cravatt; Matthew P Gillum
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

5.  Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.

Authors:  Zhongyi Chen; Lilu Guo; Yongqin Zhang; Rosemary L Walzem; Julie S Pendergast; Richard L Printz; Lindsey C Morris; Elena Matafonova; Xavier Stien; Li Kang; Denis Coulon; Owen P McGuinness; Kevin D Niswender; Sean S Davies
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

Review 6.  Modulating the endocannabinoid system in human health and disease--successes and failures.

Authors:  Pál Pacher; George Kunos
Journal:  FEBS J       Date:  2013-04-22       Impact factor: 5.542

Review 7.  The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; Varman T Samuel; Kitt F Petersen; Gerald I Shulman
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

Review 8.  Thyroid hormone signaling in energy homeostasis and energy metabolism.

Authors:  Elizabeth A McAninch; Antonio C Bianco
Journal:  Ann N Y Acad Sci       Date:  2014-02-20       Impact factor: 5.691

9.  Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance.

Authors:  Georgia Balsevich; Martin Sticht; Nicole P Bowles; Arashdeep Singh; Tiffany T Y Lee; Zhiying Li; Prasanth K Chelikani; Francis S Lee; Stephanie L Borgland; Cecilia J Hillard; Bruce S McEwen; Matthew N Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

Review 10.  Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Trends Pharmacol Sci       Date:  2017-05-24       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.